We are live on ! Find out more
SCM

Segantii Capital Management Portfolio holdings

AUM $1.54B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+30.97%
1 Year Est. Return
+16.73%
3 Year Est. Return
+33.11%
5 Year Est. Return
+149.98%
10 Year Est. Return
+416.67%
AUM
$2.16B
AUM Growth
+$867M
Cap. Flow
+$762M
Cap. Flow %
35.27%
Top 10 Hldgs %
44.32%
Holding
140
New
79
Increased
8
Reduced
7
Closed
40

Top Buys

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$171M
2
NIO icon
NIO
NIO
+$99.7M
3
SE icon
Sea Limited
SE
+$97.9M
4
XPEV icon
XPeng
XPEV
+$78.5M
5
XLNX
Xilinx Inc
XLNX
+$67.3M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$72.7M
2
YUMC icon
Yum China
YUMC
+$68.3M
3
ZLAB icon
Zai Lab
ZLAB
+$61.2M
4
TIF
Tiffany & Co.
TIF
+$59.9M
5
WTW icon
Willis Towers Watson
WTW
+$50.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.26%
2 Technology 9.32%
3 Communication Services 8.35%
4 Healthcare 7.65%
5 Financials 4.42%

Similar funds

Segantii Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Segantii Capital Management held 140 positions worth $2.16B, up 67% from $1.29B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Segantii Capital Management deployed $762M of net new capital in Q4 2020, opening 79 new positions and adding to 8 existing holdings. Its largest new stake was Varian Medical Systems, Inc.: 986,502 shares worth $173M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 16% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Yum China, an estimated $68.3M trimmed.

  • Segantii Capital Management's largest Q4 2020 buy was Varian Medical Systems, Inc.: 986,502 shares worth $173M.
  • Segantii Capital Management added most to DouYu International Holdings in Q4 2020, an estimated $37.2M increase.
  • Segantii Capital Management's biggest Q4 2020 reduction was Yum China, cutting an estimated $68.3M.
  • Segantii Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $72.7M.
  • Segantii Capital Management's ten largest holdings make up 44% of its $2.16B portfolio in Q4 2020.
  • Segantii Capital Management opened 79 new positions and closed 40 in Q4 2020.
  • Segantii Capital Management's portfolio value rose 67% quarter-over-quarter to $2.16B.

Based on Segantii Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.